ABL Bio-Technologies Ltd
ABL Bio Technologies Limited is an India-based company. The company is engaged in bio technology industry.
- Market Cap ₹ 0.66 Cr.
- Current Price ₹ 0.81
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 21.9
- Dividend Yield 0.00 %
- ROCE -0.50 %
- ROE -0.97 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.04 times its book value
Cons
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | TTM | |
---|---|---|---|
0.04 | 0.00 | 0.00 | |
0.57 | 0.12 | 0.08 | |
Operating Profit | -0.53 | -0.12 | -0.08 |
OPM % | -1,325.00% | ||
0.00 | 0.01 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 |
Depreciation | 0.07 | 0.07 | 0.08 |
Profit before tax | -0.60 | -0.18 | -0.16 |
Tax % | 0.00% | 0.00% | |
-0.60 | -0.18 | -0.13 | |
EPS in Rs | -0.73 | -0.22 | -0.17 |
Dividend Payout % | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 19% |
Stock Price CAGR | |
---|---|
10 Years: | -14% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | -1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | |
---|---|---|
Equity Capital | 8.20 | 8.20 |
Reserves | 10.54 | 10.36 |
16.96 | 17.10 | |
9.54 | 9.58 | |
Total Liabilities | 45.24 | 45.24 |
34.86 | 34.80 | |
CWIP | 0.00 | 0.00 |
Investments | 1.30 | 1.30 |
9.08 | 9.14 | |
Total Assets | 45.24 | 45.24 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | |
---|---|---|
Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | |
---|---|---|
Debtor Days | 2,920.00 | |
Inventory Days | 0.00 | |
Days Payable | ||
Cash Conversion Cycle | 2,920.00 | |
Working Capital Days | -8,942.50 | |
ROCE % | -0.50% |
Documents
Announcements
- Standalone Financial Results, Limited Review Report for September 30, 2016 14 Nov 2016
- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016 22 Oct 2016
- Limited Review Report for June 30, 2016 21 Oct 2016
- Board Meeting Intimation for Results 21 Oct 2016
- Outcome of AGM 30 Sep 2016